Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a minor update to the page version. No substantive study information appears to be altered.
    Difference
    0.1%
    Check dated 2026-06-05T23:49:23.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a minor update to the page metadata.
    Difference
    0.1%
    Check dated 2026-05-15T11:17:41.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:17.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision version updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:16.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:44.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:54:07.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.